Jump to content

Oleksandr Nevzghoda

From Medico-Pharmaceutical Law Universe (by Lumen SI)
Revision as of 00:52, 12 November 2026 by Valentin (talk | contribs) (Add complete multilingual reference and language navigation)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Oleksandr Nevzghoda is recorded as an author in the public publication source below. This is a publication-linked research record, not a complete biography.

Documented work

Coauthor of the 2025 study of combined anti-tuberculosis medicines in Annals of Mechnikov’s Institute.

Research context: Content analysis of registered products, manufacturers and formulary coverage. The study design is not a clinical efficacy trial.

Named collaborators on this work: Alina Osyntseva, Valentyn Shapovalov, Iurii Titarenko, Viktoria Dovzhuk, Viktoriia Shapovalova, Valerii Shapovalov.

Inclusion records authorship of the cited work, not endorsement of every later Vision 2035 proposal. Publication affiliations are historical unless separately updated.

See People and attribution and Research network.